Howard Z. Thom
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model.
Journal: Health technology assessment (Winchester, England)
Published: August 11, 2026
Commentary on "matching-adjusted indirect comparison of enzalutamide versus darolutamide doublet in mHSPC".
Journal: Future oncology (London, England)
Published: August 08, 2026
Correction: Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder Group.
Journal: PharmacoEconomics
Published: June 04, 2026
Treatment recommendations based on network meta-analysis: Rules for risk-averse decision-makers.
Journal: Research synthesis methods
Published: February 02, 2026
Population-adjusted network meta-analyses provide new insights into the efficacy of treatment alternatives for metastatic castration-sensitive prostate cancer.
Journal: Journal of comparative effectiveness research
Published: January 06, 2026
Developing a Comprehensive Framework for Cost-Effectiveness Evaluation in Metastatic Castration-Sensitive Prostate Cancer: Insights from a Systematic Review.
Journal: PharmacoEconomics
Published: August 03, 2025
Defining Activity-Based Subgroups in Multiple Sclerosis: A Review and Framework Proposal.
Journal: European journal of neurology
Published: August 01, 2025
External Validation of the MicroSimulation Core Obesity Model (MS-COM) to Predict Cardiovascular Outcomes, Mortality and Type 2 Diabetes Mellitus Incidence and Assess Cost Effectiveness.
Journal: PharmacoEconomics
Published: July 06, 2025
Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data.
Journal: Prostate cancer and prostatic diseases
Published: June 09, 2025
Spectrum of Models for Assessing the Cost Effectiveness of Total Knee Replacement Implants: A Comparison of Discrete-Time Cohort Markov and Continuous-Time Individual-Level Multistate Models.
Journal: PharmacoEconomics
Published: May 20, 2025
Indirect treatment comparisons of darolutamide plus docetaxel and androgen deprivation therapy in patients with metastatic hormone-sensitive prostate cancer.
Journal: Scientific reports
Published: April 30, 2025
Last Updated: 09/26/2026